Cullinan Therapeutics, Inc. (CGEM) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $49.0K | — |
| 2024 | $0 | -100.0% |
| 2023 | $208.0K | -81.6% |
| 2022 | $1.13M | — |
| 2021 | $0 | -100.0% |
| 2020 | $10.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $49.0K | — |
| 2024 | $0 | -100.0% |
| 2023 | $208.0K | -81.6% |
| 2022 | $1.13M | — |
| 2021 | $0 | -100.0% |
| 2020 | $10.0K | — |